Literature DB >> 11604590

Role of viruses in systemic lupus erythematosus and Sjögren syndrome.

J A James1, J B Harley, R H Scofield.   

Abstract

Systemic lupus erythematosus and Sjögren syndrome remain elusive in the description of their underlying etiologic causes and pathogenic mechanisms. Although underlying genetic predisposition appears to contribute to both diseases based on twin and other genetic studies, additional factors must play a role. Over the decades additional factors, such as hormonal influence, UV light, environmental exposures (e.g., silica, solvents), and infectious agents have been postulated to play a role. Over the past few years additional information has been published concerning roles of various infectious agents in both lupus and Sjögren syndrome. Although the understanding of this field is still incomplete, significant advances are being made.

Entities:  

Mesh:

Year:  2001        PMID: 11604590     DOI: 10.1097/00002281-200109000-00005

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  21 in total

Review 1.  Immunopathogenesis of Sjögren's syndrome.

Authors:  Andrea T Borchers; Stanley M Naguwa; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

Review 2.  Recent advances in understanding molecular mechanisms in the pathogenesis and antibody profile of Sjögren's syndrome.

Authors:  Roland Jonsson; Tom P Gordon; Yrjö T Konttinen
Journal:  Curr Rheumatol Rep       Date:  2003-08       Impact factor: 4.592

Review 3.  Gender differences in autoimmunity associated with exposure to environmental factors.

Authors:  K Michael Pollard
Journal:  J Autoimmun       Date:  2011-12-03       Impact factor: 7.094

Review 4.  Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop.

Authors:  Frederick W Miller; Lars Alfredsson; Karen H Costenbader; Diane L Kamen; Lorene M Nelson; Jill M Norris; Anneclaire J De Roos
Journal:  J Autoimmun       Date:  2012-06-25       Impact factor: 7.094

5.  Augmented interferon-alpha pathway activation in patients with Sjögren's syndrome treated with etanercept.

Authors:  Clio P Mavragani; Timothy B Niewold; Niki M Moutsopoulos; Stanley R Pillemer; Sharon M Wahl; Mary K Crow
Journal:  Arthritis Rheum       Date:  2007-12

6.  Human cytomegalovirus pp65 lower matrix protein: a humoral immunogen for systemic lupus erythematosus patients and autoantibody accelerator for NZB/W F1 mice.

Authors:  M Chang; M-R Pan; D-Y Chen; J-L Lan
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

7.  Concurrence of Sjögren's syndrome in a patient with Chlamydia-induced reactive arthritis; an unusual finding.

Authors:  Hyun Kyu Chang; Ki Tae Bang; Bo Han Lee; Jung Hyuk Kim; Kang Woo Bae; Myong Jin Kim; Seong-Kyu Kim
Journal:  Korean J Intern Med       Date:  2006-06       Impact factor: 2.884

8.  Cross-reaction between antibodies to the major epitope of Ro60 kD autoantigen and a homologous peptide of Coxsackie virus 2B protein.

Authors:  E A Stathopoulou; J G Routsias; E A Stea; H M Moutsopoulos; A G Tzioufas
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

9.  Disease activity in systemic lupus erythematosus correlates with expression of the transcription factor AT-rich-interactive domain 3A.

Authors:  Julie M Ward; Kira Rose; Courtney Montgomery; Indra Adrianto; Judith A James; Joan T Merrill; Carol F Webb
Journal:  Arthritis Rheumatol       Date:  2014-12       Impact factor: 10.995

10.  Sjögren's syndrome: an autoimmune disorder with otolaryngological involvement.

Authors:  M Tucci; C Quatraro; F Silvestris
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-06       Impact factor: 2.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.